Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,212
Closed -$397K 118
2020
Q1
$397K Buy
5,212
+77
+1% +$6.56K 0.15% 85
2019
Q4
$455K Buy
5,135
+19
+0.4% +$1.58K 0.12% 82
2019
Q3
$388K Buy
5,116
+265
+5% +$18.2K 0.1% 96
2019
Q2
$350K Buy
4,851
+331
+7% +$26K 0.09% 108
2019
Q1
$364K Sell
4,520
-1,517
-25% -$124K 0.09% 110
2018
Q4
$556K Sell
6,037
-219
-4% -$19.3K 0.13% 77
2018
Q3
$592K Buy
6,256
+456
+8% +$43.2K 0.12% 76
2018
Q2
$538K Sell
5,800
-28
-0.5% -$2.73K 0.12% 77
2018
Q1
$551K Buy
+5,828
New +$640K 0.16% 62
2017
Q4
Sell
-4,232
Closed -$376K 74
2017
Q3
$376K Buy
4,232
+38
+0.9% +$2.89K 0.08% 80
2017
Q2
$312K Sell
4,194
-625
-13% -$42K 0.08% 69
2017
Q1
$317K Sell
4,819
-75
-2% -$4.71K 0.08% 61
2016
Q4
$295K Buy
4,894
+741
+18% +$45.2K 0.09% 49
2016
Q3
$235K Sell
4,153
-160
-4% -$10.4K 0.06% 65
2016
Q2
$277K Buy
4,313
+111
+3% +$6.76K 0.09% 43
2016
Q1
$259K Sell
4,202
-167
-4% -$9.31K 0.09% 37
2015
Q4
$249K Buy
+4,369
New +$252K 0.11% 37

Other funds holding ABBV

Private Vista's ABBV Position: Q2 2020 in Review

Private Vista sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 5,212 shares — an estimated $397K sold.

Private Vista first reported a position in ABBV in Q4 2015 and held it in 17 quarters. The position peaked at $592K in Q3 2018. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Private Vista reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
  • Private Vista sold 5,212 AbbVie shares in Q2 2020, an estimated $397K.
  • Private Vista first reported a position in AbbVie in Q4 2015 and held it in 17 quarters.
  • Private Vista's AbbVie position peaked at $592K in Q3 2018.
  • 2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Private Vista's 13F filing for Q2 2020, filed 31 Jul 2020.